Duke Capital Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

xilisxilis.comSep 2022 · $19M

Xilis, Inc. was a company that developed micro-organosphere (MOS) technology for laboratory use; the company has closed and its MOS technology is now sold by Uniform Bio as the MOSgen benchtop instrument.

BiotechHardwareHealthtech

Co-investorsFPV

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.